Barrett’s Esophagus: Clinical Issues - 10/08/11
Corresponding author. University of Texas Southwestern Medical Center, Dallas, TX 75216.Résumé |
Barrett’s esophagus has been defined conceptually as the condition in which any extent of metaplastic columnar epithelium that predisposes to cancer development replaces the stratified squamous epithelium that normally lines the distal esophagus. The condition develops as a consequence of gastroesophageal reflux disease. Barrett’s metaplasia has clinical importance primarily because of its malignant predisposition, and virtually all of the contentious clinical issues in Barrett’s esophagus are related in some way to its cancer risk. This article considers some key clinical issues that impact the management of patients with Barrett’s esophagus.
Le texte complet de cet article est disponible en PDF.Keywords : Barrett’s esophagus, Gastroesophageal reflux disease, Intestinal metaplasia, Esophageal adenocarcinoma
Plan
| Supported by the Office of Medical Research, Department of Veterans Affairs and the National Institutes of Health (DK63621 to R.F.S.) |
Vol 21 - N° 1
P. 1-7 - janvier 2011 Retour au numéro
Article précédent
- Preface
- Irving Waxman
- Barrett’s Esophagus Surveillance: When, How Often, Does It Work?
- Bryson W. Katona, Gary W. Falk
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?